Generics 44

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ticagrelor manufacturers

44 products found

Filters

44 products found

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Albania , Cyprus , Estonia , Greece , Iraq , Italy , Kosovo , Latvia , Libya , Lithuania , Philippines , Vietnam
Registered in
Albania , Greece , Kosovo
Available for
Licensing with supply, Distribution only
Manufacturer #17046

It is one of the fastest-growing pharmaceutical firms and a top investor in Rx and Healthcare solutions. The company has been awarded several prizes for its performance and growing business units and has recently been characterized as one of the local economy gems. Based in Europe.

Manufacturer usually replies in 6 days

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #16163
As a result of a strategic agreement with a company delivering an attractive high-quality portfolio with European supply, it is a trustworthy B2B partner with more than 30 years of experience in the out-licensing business model. The organization is a reliable commercial partner that takes a customer-centric approach and strives for long-term partnership development to secure market success.

Manufacturer usually replies in 6 days

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Albania
Comments
Ref: Brilique®
Manufacturer #252

Manufacturer usually replies in 2 days

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Bolivia , Chile , Colombia , Costa Rica , Dominican Republic , El Salvador , Guatemala , Honduras , Nicaragua , Panama , Paraguay , Peru , Ukraine , Uruguay , Venezuela
Comments
DCP ongoing, RMS DK
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #419

Manufacturer usually replies in 2 days

ticagrelor

Tablets 60 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #17047
A pharmaceutical manufacturer based in the EU that sells its products in Europe, the Middle East, CIS, LATAM, and Asia. Key production lines are pharmaceuticals, bio and nanopharmaceuticals, medical devices, and nutraceuticals. The main therapeutic area is oncology.

Manufacturer usually replies in 10 days

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #519

Manufacturer usually replies in 6 days

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #21467

Manufacturer usually replies in 10 days

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Brilique
Manufacturer #15925
The global pharmaceutical manufacturer that deals with affordable but high-quality drugs that help in getting exceptional aftercare services in terms of pharmaceutical products. Their products are innovated and made at the lab and then completely tested so that the best results could be achieved.

Manufacturer usually replies in 7 days

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 11 days

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Saudi Arabia , Turkey
Available for
Licensing with supply
Comments
Reference product: Antithrombotic
Manufacturer #19112
A pharmaceutical manufacturer based in the EU that develops and produces generic medicines and sells its products in the EU, North America, LATAM, and Africa. Main therapeutic areas include diabetes, urology, and antidepressant. The company possesses its own R&D and regulatory department.

Manufacturer usually replies in 6 days

ticagrelor

Tablets, film coated 60mg, 90mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Unavailable markets
Albania
Manufacturer #281
It is a leading European pharmaceutical firm that strives to create a powerful global brand with innovative goods and services, as well as bold and pioneering activities, by working passionately to heal the lives they touch. The business was founded in the 1900s. In the interest of public health and the national economy, the firm launched the project to promote public awareness about the unintentional use of medications.

Manufacturer usually replies in 8 days

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP
Unavailable markets
Iraq , Kazakhstan , Ukraine , Uzbekistan , Vietnam
Comments
DCP submitted
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

ticagrelor

Tablets 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Malaysia
Manufacturer #15189
The company, which was founded in 1989, is involved in developing, manufacturing, and distributing a wide range of formulations for anti-infectives, cardiovascular, anti-diabetic, dermatological, and hormone treatment. The corporation has a global presence in 170 + countries, 60+ WHO-prequalified medications, and 3700+ product registrations.

Manufacturer usually replies in 9 days

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Comments
Dossier availability date: Q2 2024
Manufacturer #18975

Manufacturer usually replies in 6 days

ticagrelor

Tablets, film coated 60 mg , 90 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Chile , Panama , Vietnam
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

ticagrelor

Tablets, film coated 60 mg, 90 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply, Distribution only
Comments
Interested in projects only for European markets.
Manufacturer #15224

Manufacturer usually replies in 7 days

ticagrelor

Tablets 90 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Manufacturer #12677

Manufacturer usually replies in 4 days

ticagrelor

Tablets 60mg,90mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Pakistan
Registered in
Pakistan
Available for
Licensing with supply, Distribution only
MAs for sale
Pakistan
Manufacturer #17919

Manufacturer usually replies in 2 days

Want to view all 44 products? Create your free account today!

Ticagrelor Manufacturers

What is Ticagrelor?

Ticagrelor is a medication used to treat and/or prevent acute coronary syndrome, heart attack, myocardial infarction as well as atherothrombotic events. The supplier of these pharmaceutical substances markets it in the form of 60mg and 90mg tablets. The developer and sole manufacturer of this is AstraZeneca, which first acquired approval to market the drug in Europe in 2010, and in the U.S. in 2011. It has since then become approved in over 100 countries worldwide, including China, Japan, India, Brazil, and many others, as Brilinta in some countries and Brilique in others. Given that the patent for the drug is still valid, other manufacturers have yet to join the market with their generic or trade name formulations of the drug. Primary alternatives to tricagrelor are other ADP receptor inhibitor class drugs: cangrelor, clopidogrel, prasugrel and ticlopidine. The retail prices per 56 (90mg) tablets of these medicines fall into an approximate range of 60,00 EUR to 70,00 EUR. Pharmaceutical specialists are welcome to browse through offers of these tablets from it’s suppliers and distributors on our pharmaceutical marketplace, or else seek out further useful medical information about the medication online at the official Brilinta website. In persons who have had a cardiac arrest or who have an acute illness, it is being used to avoid a significant or life-threatening cardiac event, as well as death. It is often used to reduce the risk of stroke in persons who have had coronary stents implanted to treat ACS. It is a drug that is used to lower the risk of that first sudden cardiac arrest in persons who have cardiovascular disease. It's also used to help individuals experiencing a mild - to - moderate stroke or myocardial infarction reduce their chances of having an even more serious stroke.

How Does Ticagrelor Works?

It prevents platelets from clumping together and causing clots, which can lead to cardiovascular disease or stroke. Ticagrelor is an inhibitor of the P2Y12 channel. The P2Y12 transmitter binds to Gi2 and other Gi enzymes, which stop adenylyl cyclase from working. PI3K, Akt, Rap1b, and k streams are all activated by Gi-mediated transmission. Antagonism of the P2Y12 receptor reduces the development of occlusive thromboses, which can reduce the risk of myocardial infarction and ischemic stroke. Ticagrelor is available as a pill to be swallowed. It's commonly taken twice a day, with or without meals. Every day, take it at the same frequency. If you can't swallow it’s tablets whole, smash them and mix them with liquid. Consume the concoction right away, then replace with water, whisk, and drink it right away again. If you have a nasal cannula, your health practitioner will show you how to start preparing this medicine for administration through it. Ticagrelor will only help you control serious heart and lung issues if you take it regularly. Even if you feel fine, keep taking ticagrelor. There is a greater chance of having a heart attack or stroke if you stop using ticagrelor. If you have got a stent, you run an increased risk of a blood clot forming in the catheter if you quit taking inoculated too soon.

The Wholesale Price of Ticagrelor

Regardless of the drugstore you visit, Ticagrelor oral tablet 90 mg costs roughly $441 for a supply of 60 tablets. The coupons, rebates, savings cards, trial deals, and free samples are all examples of these pharmaceutical susbstance’s offerings. Some deals can be printed directly from the website, while others necessitate authentication.

Navigating Our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of these offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and these substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Ticagrelor. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where this medicine is already registered in. Manufacturers also have special, and delivery terms.

Establishing Commercial Ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Ticagrelor manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.